| Title |
Overcoming Adaptive Resistance to KRAS Inhibitors Through Vertical Pathway Targeting
|
|---|---|
| Published in |
Clinical Cancer Research, April 2020
|
| DOI | 10.1158/1078-0432.ccr-19-4060 |
| Pubmed ID | |
| Authors |
Rona Yaeger, David B. Solit |
X Demographics
The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 40% |
| Mexico | 1 | 5% |
| Spain | 1 | 5% |
| Colombia | 1 | 5% |
| India | 1 | 5% |
| Unknown | 8 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 35% |
| Scientists | 7 | 35% |
| Science communicators (journalists, bloggers, editors) | 3 | 15% |
| Practitioners (doctors, other healthcare professionals) | 3 | 15% |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 36 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 17% |
| Student > Ph. D. Student | 6 | 17% |
| Student > Bachelor | 3 | 8% |
| Student > Postgraduate | 2 | 6% |
| Student > Master | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 17 | 47% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 12 | 33% |
| Medicine and Dentistry | 2 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
| Immunology and Microbiology | 1 | 3% |
| Agricultural and Biological Sciences | 1 | 3% |
| Other | 2 | 6% |
| Unknown | 17 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 October 2022.
All research outputs
#1,123,068
of 25,775,807 outputs
Outputs from Clinical Cancer Research
#749
of 13,310 outputs
Outputs of similar age
#29,949
of 398,280 outputs
Outputs of similar age from Clinical Cancer Research
#23
of 166 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,310 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 398,280 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 166 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.